D A Noe

1.5k total citations
22 papers, 1.2k citations indexed

About

D A Noe is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, D A Noe has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Molecular Biology and 4 papers in Hematology. Recurrent topics in D A Noe's work include Cancer Treatment and Pharmacology (10 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer therapeutics and mechanisms (4 papers). D A Noe is often cited by papers focused on Cancer Treatment and Pharmacology (10 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer therapeutics and mechanisms (4 papers). D A Noe collaborates with scholars based in United States and Italy. D A Noe's co-authors include L B Grochow, Eric K. Rowinsky, S E Sartorius, David S. Ettinger, Ross C. Donehower, Barbara G. Lubejko, Arlene A. Forastiere, Mark R. Gilbert, William P. McGuire and Bernard J. Clark and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Clinical Chemistry.

In The Last Decade

D A Noe

22 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D A Noe United States	16	650	455	191	180	123	22	1.2k
Jean Marc Extra France	11	857 1.3×	410 0.9×	210 1.1×	173 1.0×	252 2.0×	21	1.7k
HM Pinedo Netherlands	16	691 1.1×	567 1.2×	119 0.6×	147 0.8×	106 0.9×	20	1.3k
Joanne Halsey United States	19	1.1k 1.7×	667 1.5×	298 1.6×	93 0.5×	154 1.3×	32	1.7k
Von Hoff United States	16	540 0.8×	295 0.6×	171 0.9×	121 0.7×	113 0.9×	39	1.1k
Daniel Mulkerin United States	18	670 1.0×	366 0.8×	229 1.2×	209 1.2×	115 0.9×	79	1.2k
Lucille Leong United States	23	691 1.1×	502 1.1×	265 1.4×	75 0.4×	270 2.2×	74	1.6k
R Plagne France	17	560 0.9×	282 0.6×	144 0.8×	140 0.8×	159 1.3×	100	1.3k
B.M.J. Cantwell United Kingdom	19	421 0.6×	338 0.7×	138 0.7×	38 0.2×	172 1.4×	52	1.1k
NH Mulder Netherlands	18	644 1.0×	510 1.1×	130 0.7×	130 0.7×	107 0.9×	58	1.1k
Gregory D. Leonard United States	13	1.4k 2.1×	517 1.1×	235 1.2×	106 0.6×	276 2.2×	30	2.0k

Countries citing papers authored by D A Noe

Since Specialization

Citations

This map shows the geographic impact of D A Noe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D A Noe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D A Noe more than expected).

Fields of papers citing papers by D A Noe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D A Noe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D A Noe. The network helps show where D A Noe may publish in the future.

Co-authorship network of co-authors of D A Noe

This figure shows the co-authorship network connecting the top 25 collaborators of D A Noe. A scholar is included among the top collaborators of D A Noe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D A Noe. D A Noe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Letrent, Stephen P., D A Noe, A. Qin, et al.. (2006). PI-13Pharmacokinetics and pharmacodynamics of a HER2 tyrosine kinase inhibitor CP-724714 in patients with advanced malignant HER2 positive solid tumors. Clinical Pharmacology & Therapeutics. 79(2). P10–P10. 2 indexed citations

Münster, Pamela N., Carolyn D. Britten, S. Minton, et al.. (2004). Phase I and pharmacokinetic (PK) Study of CP-724,714, an oral human epidermal growth factor receptor-2 (HER-2) selective tyrosine kinase inhibitor. Journal of Clinical Oncology. 22(14_suppl). 3082–3082. 1 indexed citations

Tolcher, A. W., James J. O’Leary, Johann S. de Bono, et al.. (2004). 137 A phase I study of an oral vascular endothelial growth factor receptor-2 (VEGFR-2) tyrosine kinase inhibitor, CP-547,632, in patients with advanced solid tumors. European Journal of Cancer Supplements. 2(8). 44–44. 7 indexed citations

Carducci, Michael A., Jeremy L. Gilbert, M K Bowling, et al.. (2001). A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule.. PubMed. 7(10). 3047–55. 166 indexed citations

Rowinsky, Eric K., D A Noe, L B Grochow, et al.. (1997). Phase I and pharmacological study of CI-980, a novel synthetic antimicrotubule agent.. PubMed. 3(3). 401–7. 15 indexed citations

John, Esther M., Marianna Zahurak, Ross C. Donehower, et al.. (1996). Phase I and pharmacologic study of sequences of paclitaxel and cyclophosphamide supported by granulocyte colony-stimulating factor in women with previously treated metastatic breast cancer.. Journal of Clinical Oncology. 14(3). 783–791. 44 indexed citations

Baker, Sharyn D., S P Khor, Alex A. Adjei, et al.. (1996). Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenase.. Journal of Clinical Oncology. 14(12). 3085–3096. 117 indexed citations

Rowinsky, Eric K., D A Noe, L B Grochow, et al.. (1995). Phase I and pharmacologic studies of pyrazoloacridine, a novel DNA intercalating agent, on single-dosing and multiple-dosing schedules.. Journal of Clinical Oncology. 13(8). 1975–1984. 33 indexed citations

Rowinsky, Eric K., D A Noe, D L Trump, et al.. (1994). Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors.. Journal of Clinical Oncology. 12(9). 1754–1763. 52 indexed citations

10.

Hilton, Adrian, et al.. (1993). Kinetic analysis of the reaction of melphalan with water, phosphate, and glutathione.. Drug Metabolism and Disposition. 21(6). 986–996. 30 indexed citations

11.

Rowinsky, Eric K., Mark R. Gilbert, William P. McGuire, et al.. (1991). Sequences of taxol and cisplatin: a phase I and pharmacologic study.. Journal of Clinical Oncology. 9(9). 1692–1703. 365 indexed citations

12.

Noe, D A, Eric K. Rowinsky, L B Grochow, et al.. (1990). Phase I and pharmacokinetic study of brequinar sodium (NSC 368390).. PubMed. 50(15). 4595–9. 32 indexed citations

13.

Grochow, L B, D A Noe, David S. Ettinger, et al.. (1989). Phase I Trial of Trimetrexate Glucuronate on a Five-Day Bolus Schedule: Clinical Pharmacology and Pharmacodynamics. JNCI Journal of the National Cancer Institute. 81(2). 124–130. 32 indexed citations

14.

Chen, Tianling, G. B. Vogelsang, Brent G. Petty, et al.. (1989). Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers.. Drug Metabolism and Disposition. 17(4). 402–405. 101 indexed citations

15.

Noe, D A, Patrick J. Murphy, William R. Bell, & J N Siegel. (1989). Acute-phase behavior of factor VIII procoagulant and other acute-phase reactants in rabbits. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 257(1). R49–R56. 15 indexed citations

16.

Hantel, A., Eric K. Rowinsky, D A Noe, et al.. (1988). Clinical and Pharmacologic Reappraisal of Dichloromethotrexate. JNCI Journal of the National Cancer Institute. 80(19). 1547–1553. 3 indexed citations

17.

Noe, D A, et al.. (1988). Clinical Pharmacology of Oral and Iv N-Methylformamide: A Pharmacologic Basis for Lack of Clinical Antineoplastic Activity. JNCI Journal of the National Cancer Institute. 80(9). 671–678. 12 indexed citations

18.

Franceschini, Guido, Yara María Franco Moreno, Laura Calabresi, et al.. (1988). Alterations in high-density lipoprotein subfractions during postprandial lipidaemia induced by fat with and without ethanol. Clinical Science. 75(2). 135–142. 18 indexed citations

19.

Noe, D A, Victor W. Weedn, & W. R. Bell. (1984). Direct spectrophotometry of serum hemoglobin: an Allen correction compared with a three-wavelength polychromatic analysis.. Clinical Chemistry. 30(5). 627–630. 71 indexed citations

20.

Noe, D A, et al.. (1982). Platelet counts during rapid massive transfusion. Transfusion. 22(5). 392–395. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact